<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27658244</article-id><article-id pub-id-type="pmc">5033598</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0161563</article-id><article-id pub-id-type="publisher-id">PONE-D-15-48124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Arms</subject><subj-group><subject>Elbow</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Arms</subject><subj-group><subject>Elbow</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Brain</subject><subj-group><subject>Cerebral Cortex</subject><subj-group><subject>Cerebellum</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Brain</subject><subj-group><subject>Cerebral Cortex</subject><subj-group><subject>Cerebellum</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Myalgia</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Nervous System</subject><subj-group><subject>Central Nervous System</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Nervous System</subject><subj-group><subject>Central Nervous System</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Sensory Receptors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Sensory Receptors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Sensory Receptors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Signal Transduction</subject><subj-group><subject>Sensory Receptors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Trials</subject><subj-group><subject>Randomized Controlled Trials</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug Research and Development</subject><subj-group><subject>Clinical Trials</subject><subj-group><subject>Randomized Controlled Trials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Clinical Trials</subject><subj-group><subject>Randomized Controlled Trials</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Decreased Brain Neurokinin-1 Receptor Availability in Chronic Tennis Elbow</article-title><alt-title alt-title-type="running-head">Substance P Receptors in Chronic Pain</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Linnman</surname><given-names>Clas</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Catana</surname><given-names>Ciprian</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sv&#x000e4;rdsudd</surname><given-names>Kurt</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Appel</surname><given-names>Lieuwe</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Engler</surname><given-names>Henry</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>L&#x000e5;ngstr&#x000f6;m</surname><given-names>Bengt</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>S&#x000f6;rensen</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Furmark</surname><given-names>Tomas</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fredrikson</surname><given-names>Mats</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Borsook</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peterson</surname><given-names>Magnus</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Center for Pain and the Brain, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children&#x02019;s Hospital, Harvard Medical School, Boston, MA, United States of America</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Uppsala PET Centre, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Uruguayan Centre of Molecular Imaging (CUDIM), Faculty of Medicine and Faculty of Sciences, University of the Republic, Montevideo, Uruguay</addr-line></aff><aff id="aff006"><label>6</label><addr-line>Department of Biochemistry and Organic Chemistry, Uppsala University, Uppsala, Sweden</addr-line></aff><aff id="aff007"><label>7</label><addr-line>Neuropsychopharmacology Section, Faculty of Medicine, Imperial College, London, United Kingdom</addr-line></aff><aff id="aff008"><label>8</label><addr-line>Department of Psychology, Uppsala University, Uppsala, Sweden</addr-line></aff><aff id="aff009"><label>9</label><addr-line>Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Paul</surname><given-names>Friedemann</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Charite Universitatsmedizin Berlin, GERMANY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceived and designed the experiments:</bold> CL KS MP.</p></list-item><list-item><p><bold>Performed the experiments:</bold> CL KS MP LA HE BL JS MF TF.</p></list-item><list-item><p><bold>Analyzed the data:</bold> CL MP CC DB MF TF LA BL.</p></list-item><list-item><p><bold>Wrote the paper:</bold> CL MP MF TF CC DB LA.</p></list-item></list>
</p></fn><corresp id="cor001">* E-mail: <email>magnus.peterson@pubcare.uu.se</email></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>9</issue><elocation-id>e0161563</elocation-id><history><date date-type="received"><day>3</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>8</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Linnman et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Linnman et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0161563.pdf"/><abstract><p>Substance P is released in painful and inflammatory conditions, affecting both peripheral processes and the central nervous system neurokinin 1 (NK1) receptor. There is a paucity of data on human brain alterations in NK1 expression, how this system may be affected by treatment, and interactions between central and peripheral tissue alterations. Ten subjects with chronic tennis elbow (lateral epicondylosis) were selected out of a larger (n = 120) randomized controlled trial evaluating graded exercise as a treatment for chronic tennis elbow (lateral epicondylosis). These ten subjects were examined by positron emission tomography (PET) with the NK1-specific radioligand 11C-GR205171 before, and eight patients were followed up after treatment with graded exercise. Brain binding in the ten patients before treatment, reflecting NK1-receptor availability (NK1-RA), was compared to that of 18 healthy subjects and, longitudinally, to the eight of the original ten patients that agreed to a second PET examination after treatment. Before treatment, patients had significantly lower NK1-RA in the insula, vmPFC, postcentral gyrus, anterior cingulate, caudate, putamen, amygdala and the midbrain but not the thalamus and cerebellum, with the largest difference in the insula contralateral to the injured elbow. No significant correlations between brain NK1-RA and pain, functional severity, or peripheral NK1-RA in the affected limb were observed. In the eight patients examined after treatment, pain ratings decreased in everyone, but there were no significant changes in NK1-RA. These findings indicate a role for the substance P (SP) / NK1 receptor system in musculoskeletal pain and tissue healing. As neither clinical parameters nor successful treatment response was reflected in brain NK1-RA after treatment, this may reflect the diverse function of the SP/NK1 system in CNS and peripheral tissue, or a change too small or slow to capture over the three-month treatment.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsr&#x000e5;det</institution></institution-wrap></funding-source><award-id>K2005-27X-15293-01A</award-id><principal-award-recipient><name><surname>Peterson</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100007051</institution-id><institution>Uppsala Universitet</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Peterson</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution>Uppsala L&#x000e4;ns Landsting</institution></funding-source><principal-award-recipient><name><surname>Peterson</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution>Stiftelsen f&#x000f6;r allm&#x000e4;nmedicin</institution></funding-source><principal-award-recipient><name><surname>Peterson</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><award-group id="award005"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100005924</institution-id><institution>International Association for the Study of Pain</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Linnman</surname><given-names>Clas</given-names></name></principal-award-recipient></award-group><funding-statement>The study was supported by grants from the Swedish Research Council (grant no. K2005-27X-15293-01A), The Amersham Fund at Uppsala University, The Research Fund at Uppsala County Council, The Family Medicine Foundation, Uppsala University and the International Association for the study of Pain (IASP) collaborative grant by Scan|Design Foundation BY INGER &#x00026; JENS BRUUN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="3"/><page-count count="13"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Because of ethical restrictions the data is only available upon request. (Public datasharing was not approved in the original IRB application or informed consent, and we do not have permission to re-contact subjects to inquire about permission. We are therefore legally restricted to upload the data.) However, data will be available on request to all interested researchers on contact with <email>Clas.Linnman@childrens.harvard.edu</email>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Because of ethical restrictions the data is only available upon request. (Public datasharing was not approved in the original IRB application or informed consent, and we do not have permission to re-contact subjects to inquire about permission. We are therefore legally restricted to upload the data.) However, data will be available on request to all interested researchers on contact with <email>Clas.Linnman@childrens.harvard.edu</email>.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Pain from the tendons that join the forearm muscles on the outside of the elbow, i.e. tennis elbow (TE) or lateral epicondylitis, has a prevalence of 1&#x02013;3% in the population [<xref rid="pone.0161563.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0161563.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0161563.ref003" ref-type="bibr">3</xref>]. Generally thought of as a persistent inflammatory process caused by initial overuse and/or repetitive microtrauma [<xref rid="pone.0161563.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0161563.ref005" ref-type="bibr">5</xref>], the cause of pain is mostly unknown [<xref rid="pone.0161563.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0161563.ref007" ref-type="bibr">7</xref>]. The unaffected arm also displays cold, heat and pressure hypersensitivity, indicating that both peripheral and central mechanisms may be involved [<xref rid="pone.0161563.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0161563.ref009" ref-type="bibr">9</xref>]. As such, the disease represents an interesting, unilateral and treatable condition that may lend itself to insight in the pathophysiology of more severe chronic pain. In chronic TE (defined as lasting more than 3 months), there are few inflammatory cells present, and tissue degeneration appears [<xref rid="pone.0161563.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0161563.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0161563.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0161563.ref012" ref-type="bibr">12</xref>]. An increase of neural fibers and transmitters, including SP, has been observed in chronic TE tissue samples [<xref rid="pone.0161563.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0161563.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0161563.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0161563.ref016" ref-type="bibr">16</xref>]. SP contributes to local neurogenic inflammation [<xref rid="pone.0161563.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0161563.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0161563.ref019" ref-type="bibr">19</xref>], promotes tissue healing [<xref rid="pone.0161563.ref020" ref-type="bibr">20</xref>], [<xref rid="pone.0161563.ref021" ref-type="bibr">21</xref>]) by enhancing inflammatory response [<xref rid="pone.0161563.ref022" ref-type="bibr">22</xref>]), and serves as a neuropeptide in the nociceptive pathway via its primary receptor, the neurokinin 1 (NK1) receptor [<xref rid="pone.0161563.ref023" ref-type="bibr">23</xref>]. NK1 receptors are widely distributed in the brain except the cerebellum [<xref rid="pone.0161563.ref024" ref-type="bibr">24</xref>] [<xref rid="pone.0161563.ref025" ref-type="bibr">25</xref>]) and are abundant in the basal ganglia, nigrostriatal pathways [<xref rid="pone.0161563.ref024" ref-type="bibr">24</xref>] and brain regions that are involved in stress, fear and affective response (e.g. limbic system (amygdala, hippocampus), hypothalamus and frontal cortex). [<xref rid="pone.0161563.ref024" ref-type="bibr">24</xref>] [<xref rid="pone.0161563.ref026" ref-type="bibr">26</xref>]. SP and increased expression of NK1 receptors has been demonstrated in human Achilles tendinosis [<xref rid="pone.0161563.ref014" ref-type="bibr">14</xref>], and we recently found that the radiolabeled NK1 receptor antagonist <sup>11</sup>C-GR205171 has elevated retention in the affected regions in TE [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>]. Here, we investigated central NK1 receptor availability (NK1-RA) in patients with unilateral chronic tennis elbow before and after therapeutic exercise [<xref rid="pone.0161563.ref028" ref-type="bibr">28</xref>]. We further sought to characterize interactions between central NK1-RA alterations, pain ratings, functional severity, symptom duration and peripheral <sup>11</sup>C-GR205171 uptake in the affected limb [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>].</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Study population</title><p>The study sample was part of a larger randomized controlled trial, evaluating graded exercise as a treatment for chronic TE, see [<xref rid="pone.0161563.ref028" ref-type="bibr">28</xref>] for details. Further, the study sample was identical to that reported in [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>], where we report peripheral uptake of <sup>11</sup>C-GR205171. Briefly, the inclusion criteria included a verified TE diagnosis, symptoms for more than three months, and age 20&#x02013;75 years. Subjects with concomitant supinator syndrome, compartment syndrome of the anconeus muscle, rhizopathy, inflammatory joint disease, fibromyalgia, previous elbow surgery, treatment by injection of steroids, within the previous three months, and an inability to understand Swedish were excluded. Further exclusion criteria for the PET study included the following: current medication interfering with the nervous or inflammatory system, substance abuse, pregnancy, recent or planned participation in another PET study, X-ray or other significant exposure to radiation, bilateral symptoms or other pain diagnosis of the upper extremities.</p><p>The diagnosis was verified by pain on palpation, stretching (Mill&#x000b4;s test), loading and Maudsley&#x000b4;s middle finger test by a general practitioner and pain specialist (MP). 120 subjects were included in the larger randomized controlled trial (RCT), and each subject recruited in the RCT was invited to participate in the PET study, until ten accepted. The RCT is registered as NCT00888225 at <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">http://clinicaltrials.gov/</ext-link>.</p><p>For a detailed description of study participants, we refer to [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>]. Briefly, five men and five women with a mean age of 48.7 years (&#x000b1;8.5 years) with an average duration of 52.0 (&#x000b1;42.9) weeks of TE pain participated in the PET study. Eight of these ten patients also participated in a second PET investigation after treatment. See <xref ref-type="table" rid="pone.0161563.t001">Table 1</xref> for details.</p><table-wrap id="pone.0161563.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.t001</object-id><label>Table 1</label><caption><title>Characteristics of the Patient Population.</title></caption><alternatives><graphic id="pone.0161563.t001g" xlink:href="pone.0161563.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Metric</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">n or mean</th><th align="left" rowspan="1" colspan="1">(SD) or %</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of participants</td><td align="left" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age, years</td><td align="left" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">48.7</td><td align="right" rowspan="1" colspan="1">(8.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">50%</td></tr><tr><td align="left" rowspan="1" colspan="1">Educational level</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Compulsory education only</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">20%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Vocational training</td><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">40%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Upper secondary school</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">College or university</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">3%</td></tr><tr><td align="left" rowspan="1" colspan="1">Marital status</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Never married</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Married or cohabiting</td><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">90%</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking habits</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Never smoked</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">50%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ex-smokers</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">30%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Current smokers</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">20%</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of present epicondylosis, weeks</td><td align="left" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">52.0</td><td align="right" rowspan="1" colspan="1">(42.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous treatments given</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSAID</td><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">40%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Acupuncture</td><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">40%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Steroid injections</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">30%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Stretching</td><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">40%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Orthosis or other fixative</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">30%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Massage</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rest</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">No previous treatment</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" rowspan="1" colspan="1">VAS 0&#x02013;100 Pain ratings</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unaffected elbow pre-treatment, n = 10</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">(2)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Affected elbow pre-treatment, n = 10</td><td align="right" rowspan="1" colspan="1">58</td><td align="right" rowspan="1" colspan="1">(10)<xref ref-type="table-fn" rid="t001fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unaffected elbow post-treatment, n = 8</td><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">(2)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Affected elbow post-treatment, n = 8</td><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">(21)<xref ref-type="table-fn" rid="t001fn003">**</xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>n = number of participants, SD = Standard Deviation, NSAID = Nonsteroidal anti-inflammatory drug, VAS = Visual Analog Scale.</p></fn><fn id="t001fn002"><p>* Significantly higher pain ratings in affected elbow, paired t-test p&#x0003c;0.001.</p></fn><fn id="t001fn003"><p>** Significant reduction of pain after treatment, paired t-test, p = 0.001.</p></fn></table-wrap-foot></table-wrap><p>In addition, eighteen healthy, pain-free control subjects (9 females, 9 males, age 35 &#x000b1; 9 years) were recruited through advertisements. Data from this control group have previously been reported in [<xref rid="pone.0161563.ref029" ref-type="bibr">29</xref>] and [<xref rid="pone.0161563.ref030" ref-type="bibr">30</xref>]. All subjects gave written informed consent before entering the study. The Regional Ethical Review Board in Uppsala, Sweden and the Radiation Safety Committee in Uppsala, Sweden approved the study</p></sec><sec id="sec004"><title>Treatment procedure and clinical parameters</title><p>All subjects, except one, had right lateralized TE. Treatment consisted of a three-month daily exercise regime performed at home, with gradually increasing load on the extensor muscles of the affected forearm, see [<xref rid="pone.0161563.ref028" ref-type="bibr">28</xref>] for details. For both PET examinations (see below), patients rated their pain on a 100 mm visual analogue scale (VAS) during maximum voluntary contraction of the forearm extensor muscles. General arm function was measured at baseline and after 3 months of treatment using the Disability of Arm, Shoulder, and Hand questionnaire (DASH) [<xref rid="pone.0161563.ref031" ref-type="bibr">31</xref>,<xref rid="pone.0161563.ref032" ref-type="bibr">32</xref>]. DASH contains 30 questions on the ability to perform activities, using a five-degree Likert scale ranging from &#x02018;no problem&#x02019; to &#x02018;impossible&#x02019;.</p></sec><sec id="sec005"><title>PET examination</title><p>The PET examinations were performed twice in eight of the ten patients, before and after the treatment protocol of the RCT. Two patients declined a second PET examination after treatment and thus only participated once in the PET examination. PET examinations were performed only once in the healthy controls.</p><p>The NK1-specific radioligand <sup>11</sup>C-GR205171, synthesized according to standard manufacturing procedures [<xref rid="pone.0161563.ref033" ref-type="bibr">33</xref>] at the Uppsala PET center was injected as a bolus, and PET scanning was performed on a Siemens ECAT EXACT HR+ whole body tomograph (CTI, Knoxville, TN, USA). The scanner enables acquisition of 63 contiguous planes of data with 2.46 mm plane spacing resulting in a total axial field of view of 155 mm. Subjects were instructed to rest quietly and relax during the investigation. Healthy controls were placed supine in the scanner, while patients were placed in prone position with their arms stretched above their heads and gently fixed, so that both the brain and, after table movement, the elbow joints of both arms could be investigated, <xref ref-type="fig" rid="pone.0161563.g001">Fig 1</xref> and [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>].</p><fig id="pone.0161563.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.g001</object-id><label>Fig 1</label><caption><title>Elevated Peripheral Uptake of <sup>11</sup>C-GR205171 in a Patient with Left-Sided Tennis-Elbow Pain.</title><p>Fig adapted from [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>]. The subject has given written informed consent, as outlined in the PLoS consent form, for the publication of the photograph.</p></caption><graphic xlink:href="pone.0161563.g001"/></fig><p>For brain imaging, a 10 min transmission scan was performed using three retractable 68Ge rotating line sources. Thereafter, a bolus of approximately 5.2 MBq/kg bodyweight (average dose 400 &#x000b1; 13 MBq), diluted in saline, total volume 5 ml was injected into the dorsal vein of the right foot, and 14 frames of dynamic data with progressively increasing duration (4 &#x000d7; 60 s, 3 &#x000d7; 120 s, 7 &#x000d7; 300 s), in total 45 min, were collected in 3D mode starting at the time of bolus injection. After the brain scan, the patients were moved and a 10-minute frame was collected over the elbow joints [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>]. In the control group, additional frames were collected over the brain. These were discarded in the current analysis to allow for comparison between patients and controls. The PET data were reconstructed to a 128 &#x000d7; 128 matrix with filter back projection, corrected for photon attenuation, decay, scattered radiation, and random coincidences according to standard procedures [<xref rid="pone.0161563.ref034" ref-type="bibr">34</xref>].</p></sec><sec id="sec006"><title>PET tracer modeling</title><p>Dynamic <sup>11</sup>C-GR205171 PET frames were realigned within scans to adjust for movements during scanning. Parametric PET images were generated using the Patlak reference tissue model [<xref rid="pone.0161563.ref035" ref-type="bibr">35</xref>] with the cerebellar cortex as a reference region for the time window between 20 and 45 minutes post-injection. The resulting Patlak image reflects neurokinin-1 receptor availability (NK1-RA). To further examine tracer uptake, we calculated Standardized Uptake Values (SUV) (i.e. adjusted for injected dose and weight) for all subjects and extracted time radioactivity curves.</p></sec><sec id="sec007"><title>Data analysis</title><p>All except one subject had right-sided TE. It can be assumed that unilateral chronic pain mostly affects the contralateral hemisphere; thus, the brain data of the one patient with left TE was flipped in the left-right direction to homogenize the data with regards to laterality, as has been done in other clinical pain studies [<xref rid="pone.0161563.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0161563.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0161563.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0161563.ref039" ref-type="bibr">39</xref>,<xref rid="pone.0161563.ref040" ref-type="bibr">40</xref>]. Based on the animal literature on NK1 receptor alterations in chronic pain, and on our previous findings in chronic whiplash disorder [<xref rid="pone.0161563.ref029" ref-type="bibr">29</xref>], region of interest (ROI) analyses were performed on the bilateral insula, ventromedial prefrontal cortex (vmPFC), the postcentral gyrus, the anterior cingulate, thalamus, caudate, putamen and amygdala. A midbrain (including periaqueductal gray) ROI was also defined. For control regions, ROI&#x000b4;s were defined for the whole brain, the left and right cerebellum, and the visual cortex (Brodmann area 17,18 &#x00026; 19). All ROI&#x000b4;s were defined from the AAL library [<xref rid="pone.0161563.ref041" ref-type="bibr">41</xref>], except for the midbrain (a 5 mm radius sphere at MNI<sub>xyz</sub> (0, -10, -30) [<xref rid="pone.0161563.ref042" ref-type="bibr">42</xref>]), the vmPFC (two 10 mm radius spheres at MNI<sub>xyz</sub> (&#x000b1;8, 36, -18) [<xref rid="pone.0161563.ref029" ref-type="bibr">29</xref>]), and the cerebellum (two 10 mm radius spheres at MNI<sub>xyz</sub> (&#x000b1;28, 72, -45).</p><p>The average NK1-RA values from all voxels included in the ROIs were extracted and t-tests were performed between healthy subjects and controls, between left and right hemispheres within the patient group, and finally within patients pre- and post-treatment. With a total of 21 ROI&#x000b4;s, the Bonferroni corrected P value of 0.05 was set at p&#x0003c;0.0024.</p><p>In addition to ROI analyses, NK1-RA differences between patients and controls were analyzed on a voxel by voxel basis using statistical parametrical mapping (SPM8) in a general linear model (GLM) with age and gender as nuisance variables. In four separate SPM8 GLM regression models, we further explored potential correlations between central NK1 receptor alterations and <italic>i)</italic> pain, <italic>ii)</italic> functional severity, <italic>iii)</italic> symptom duration and <italic>iv)</italic> peripheral <sup>11</sup>C-GR205171 uptake in the affected limb [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>]. For all SPM analyses, the cluster significance level was set at p&#x0003c;0.05 family wise error corrected.</p></sec><sec id="sec008"><title>Treatment responses</title><p>NK1-RA alterations after treatment were evaluated in the 8 available patients in a ROI analysis with paired t-test, and in a whole brain GLM with paired t-tests. Moreover, treatment-induced changes in pain ratings and in peripheral uptake of <sup>11</sup>C-GR205171 were evaluated in relation to treatment-induced changes in CNS uptake of <sup>11</sup>C-GR205171.</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Pain ratings, disability and treatment response</title><p>Pain was rated on a 100 mm visual analogue scale (VAS), during maximum voluntary contraction of the forearm extensor muscles. Patients rated their pain in the affected arm an average 58 (&#x000b1;10) and in the unaffected arm an average of 5 (&#x000b1;2), before treatment (p&#x0003c;0.0001). After treatment, patients rated their pain in the affected arm an average of 25 (treatment effect p = 0.007). Treatment also led to a significant reduction in disability (DASH change = 11 points, p = 0.001).</p><p>Seven of the eight subjects had substantial (39&#x02013;96%) reductions in VAS ratings after treatment, while one subject essentially rated pain the same before and after treatment (VAS<sub>pre</sub> = 68, VAS<sub>post</sub> = 67).</p></sec><sec id="sec011"><title>Central neurokinin-1 receptor availability</title><p>Before treatment, patients had significantly lower NK1-RA in most ROIs (insula, vmPFC, right postcentral gyrus, anterior cingulate, right caudate, putamen, amygdala and the midbrain). There were no group differences in the thalamus. With regards to the control regions, there were no group differences in the cerebellum (Patlak reference region with no NK1 receptors), but both whole brain and primary visual cortex NK1-RA were significantly lower in the patient group, see <xref ref-type="table" rid="pone.0161563.t002">Table 2</xref> and <xref ref-type="fig" rid="pone.0161563.g002">Fig 2</xref>.</p><fig id="pone.0161563.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.g002</object-id><label>Fig 2</label><caption><title>Average Patlak Values Signifying NK1-RA for Regions of Interest Across All Healthy Controls.</title><p>(n = 18, in blue), patients pre-treatment (n = 10, in red) and patients post-treatment (n = 8, in green).</p></caption><graphic xlink:href="pone.0161563.g002"/></fig><table-wrap id="pone.0161563.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.t002</object-id><label>Table 2</label><caption><title>Region of Interest Analysis.</title><p>Average NK1-RA (Normalized Patlak Slope Values) in Regions of Interest. HC vs. Pat Indicates t-test Between 18 Healthy Controls and 10 Patients with Chronic Tennis Elbow. Pat<sub>pre</sub> vs. Pat<sub>post</sub> Indicates Paired t-tests in 8 Patients Examined Before (Pre) and After (Post) a Three-months Treatment Program of Daily Exercise.</p></caption><alternatives><graphic id="pone.0161563.t002g" xlink:href="pone.0161563.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">ROI</th><th align="left" rowspan="1" colspan="1">Healthy (stdev)</th><th align="left" rowspan="1" colspan="1">Patients Pre</th><th align="left" rowspan="1" colspan="1">Patients post</th><th align="left" rowspan="1" colspan="1">HC vs. Pat</th><th align="left" rowspan="1" colspan="1">Pat<sub>pre</sub> vs. Pat<sub>post</sub></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Cortical regions</italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">L Insula</td><td align="left" rowspan="1" colspan="1">76.5(6.8)</td><td align="left" rowspan="1" colspan="1">63.3(9.2)</td><td align="left" rowspan="1" colspan="1">61.9(7.4)</td><td align="left" rowspan="1" colspan="1">0.00020<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">R Insula</td><td align="left" rowspan="1" colspan="1">77.4 (6.7)</td><td align="left" rowspan="1" colspan="1">64.9(8.3)</td><td align="left" rowspan="1" colspan="1">60.8(11.7)</td><td align="left" rowspan="1" colspan="1">0.00019<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">L vmPFC</td><td align="left" rowspan="1" colspan="1">71.4(5.7)</td><td align="left" rowspan="1" colspan="1">61.0(4.8)</td><td align="left" rowspan="1" colspan="1">59.2(9.3)</td><td align="left" rowspan="1" colspan="1">0.000042<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" rowspan="1" colspan="1">R vmPFC</td><td align="left" rowspan="1" colspan="1">74.6(8.4)</td><td align="left" rowspan="1" colspan="1">61.1(6.7)</td><td align="left" rowspan="1" colspan="1">56.5(12.7)</td><td align="left" rowspan="1" colspan="1">0.00018<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">L Postcentral</td><td align="left" rowspan="1" colspan="1">73.5(7.2)</td><td align="left" rowspan="1" colspan="1">64.5(6.3)</td><td align="left" rowspan="1" colspan="1">62.1(7.4)</td><td align="left" rowspan="1" colspan="1">0.0028</td><td align="left" rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" rowspan="1" colspan="1">R Postcentral</td><td align="left" rowspan="1" colspan="1">74.0(6.9)</td><td align="left" rowspan="1" colspan="1">64.5(5.7)</td><td align="left" rowspan="1" colspan="1">61.2(7.1)</td><td align="left" rowspan="1" colspan="1">0.0011<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" rowspan="1" colspan="1">L ACC</td><td align="left" rowspan="1" colspan="1">70.4(6.7)</td><td align="left" rowspan="1" colspan="1">60.8(6.8)</td><td align="left" rowspan="1" colspan="1">53.9(13.3)</td><td align="left" rowspan="1" colspan="1">0.0014<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">R ACC</td><td align="left" rowspan="1" colspan="1">71.5(8.8)</td><td align="left" rowspan="1" colspan="1">57.0(9.1)</td><td align="left" rowspan="1" colspan="1">57.3(9.4)</td><td align="left" rowspan="1" colspan="1">0.00035<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Subcortical regions</italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">L Thalamus</td><td align="left" rowspan="1" colspan="1">58.4(10.3)</td><td align="left" rowspan="1" colspan="1">51.8(9.5)</td><td align="left" rowspan="1" colspan="1">53.8(11.9)</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">R Thalamus</td><td align="left" rowspan="1" colspan="1">58.5(12.8)</td><td align="left" rowspan="1" colspan="1">51.2(8.7)</td><td align="left" rowspan="1" colspan="1">51.5(10.7)</td><td align="left" rowspan="1" colspan="1">0.12</td><td align="left" rowspan="1" colspan="1">0.58</td></tr><tr><td align="left" rowspan="1" colspan="1">L Caudate</td><td align="left" rowspan="1" colspan="1">72.6(14.0)</td><td align="left" rowspan="1" colspan="1">62.5(7.7)</td><td align="left" rowspan="1" colspan="1">61.3(6.6)</td><td align="left" rowspan="1" colspan="1">0.045</td><td align="left" rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" rowspan="1" colspan="1">R Caudate</td><td align="left" rowspan="1" colspan="1">71.5(9.4)</td><td align="left" rowspan="1" colspan="1">59.0(8.3)</td><td align="left" rowspan="1" colspan="1">57.4(7.0)</td><td align="left" rowspan="1" colspan="1">0.0017<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.070</td></tr><tr><td align="left" rowspan="1" colspan="1">L Putamen</td><td align="left" rowspan="1" colspan="1">107.4(11.0)</td><td align="left" rowspan="1" colspan="1">86.2(11.0)</td><td align="left" rowspan="1" colspan="1">85.4(6.4)</td><td align="left" rowspan="1" colspan="1">0.000046<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1">R Putamen</td><td align="left" rowspan="1" colspan="1">105.7(10.7)</td><td align="left" rowspan="1" colspan="1">86.4(8.3)</td><td align="left" rowspan="1" colspan="1">85.4(9.9)</td><td align="left" rowspan="1" colspan="1">0.000042<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">L Amygdala</td><td align="left" rowspan="1" colspan="1">68.0(7.3)</td><td align="left" rowspan="1" colspan="1">58.3(5.2)</td><td align="left" rowspan="1" colspan="1">56.5(10.8)</td><td align="left" rowspan="1" colspan="1">0.0011<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" rowspan="1" colspan="1">R Amygdala</td><td align="left" rowspan="1" colspan="1">70.6(8.7)</td><td align="left" rowspan="1" colspan="1">55.9(5.0)</td><td align="left" rowspan="1" colspan="1">56.7(7.0)</td><td align="left" rowspan="1" colspan="1">0.000049<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" rowspan="1" colspan="1">Midbrain</td><td align="left" rowspan="1" colspan="1">107.4(11.0)</td><td align="left" rowspan="1" colspan="1">86.2(11.0)</td><td align="left" rowspan="1" colspan="1">85.4(6.4)</td><td align="left" rowspan="1" colspan="1">0.000046<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Control regions</italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Whole Brain</td><td align="left" rowspan="1" colspan="1">71.2(6.6)</td><td align="left" rowspan="1" colspan="1">60.5(5.7)</td><td align="left" rowspan="1" colspan="1">58.4(7.1)</td><td align="left" rowspan="1" colspan="1">0.00021<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.090</td></tr><tr><td align="left" rowspan="1" colspan="1">Primary visual</td><td align="left" rowspan="1" colspan="1">88.4(10.0)</td><td align="left" rowspan="1" colspan="1">72.2(11.0)</td><td align="left" rowspan="1" colspan="1">70.9(6.3)</td><td align="left" rowspan="1" colspan="1">0.00050<xref ref-type="table-fn" rid="t002fn002">*</xref></td><td align="left" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">L Cerebellum</td><td align="left" rowspan="1" colspan="1">6.2(2.3)</td><td align="left" rowspan="1" colspan="1">7.2(2.3)</td><td align="left" rowspan="1" colspan="1">7.1(4.8)</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">R Cerebellum</td><td align="left" rowspan="1" colspan="1">7.6(2.4)</td><td align="left" rowspan="1" colspan="1">8.4(3.1)</td><td align="left" rowspan="1" colspan="1">7.1(4.4)</td><td align="left" rowspan="1" colspan="1">0.45</td><td align="left" rowspan="1" colspan="1">0.47</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>L left, R Right, vmPFC ventromedial Prefronal Cortex, ACC Anterior Cingulate Cortex</p></fn><fn id="t002fn002"><p>* Significant at p&#x0003c;0.0024 (Bonferroini corrected p&#x0003c;0.05)</p></fn></table-wrap-foot></table-wrap><p>The voxelwise SPM analysis indicated that the most pronounced NK1-RA alterations (i.e. lower NK1-RA in patients) occurred in the posterior insula, contralateral to the injured elbow, see <xref ref-type="table" rid="pone.0161563.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0161563.g003">Fig 3</xref>. There were no significant correlations between brain NK1-RA and <italic>i</italic>) pain ratings, <italic>ii</italic>) functional severity, <italic>iii</italic>) symptom duration or <italic>iv</italic>) peripheral <sup>11</sup>C-GR205171 uptake (data from [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>]) in the affected limb.</p><fig id="pone.0161563.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.g003</object-id><label>Fig 3</label><caption><title>Regions with Significantly Lower NK1-RA in the Patient Group Pre-Treatment, as Compared to the Healthy Group, at a Family Wise Error Corrected p-value of &#x0003c;0.05 in the Insula.</title><p>The color bar indicates t-values. The background image is the average Patlak-slope value of all patients and controls (note the absence of NK1-receptors in the cerebellum).</p></caption><graphic xlink:href="pone.0161563.g003"/></fig><table-wrap id="pone.0161563.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.t003</object-id><label>Table 3</label><caption><title>SPM Analysis Results.</title><p>Significant Reductions in NK1-RA in the Patient Group as Contrasted to the Healthy Control Group when Controlled for Age and Gender.</p></caption><alternatives><graphic id="pone.0161563.t003g" xlink:href="pone.0161563.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Region</th><th align="left" rowspan="1" colspan="1">Cluster size</th><th align="left" rowspan="1" colspan="1">Peak P<sub>FWE</sub></th><th align="left" rowspan="1" colspan="1">T-value</th><th align="left" rowspan="1" colspan="1">MNI<sub>X,Y,Z</sub></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Left Insula</td><td align="left" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">0.019</td><td align="left" rowspan="1" colspan="1">5.2</td><td align="left" rowspan="1" colspan="1">-36, -18, 5</td></tr><tr><td align="left" rowspan="1" colspan="1">Right ParaHippocampal Gyrus</td><td align="left" rowspan="1" colspan="1">141</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">4.91</td><td align="left" rowspan="1" colspan="1">30, 2, -37</td></tr><tr><td align="left" rowspan="1" colspan="1">(Right Middle Temporal Pole)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.6</td><td align="left" rowspan="1" colspan="1">(42, 4, -27)</td></tr><tr><td align="left" rowspan="1" colspan="1">(Right Fusiform Gyrus)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.71</td><td align="left" rowspan="1" colspan="1">(36, -6, -37)</td></tr><tr><td align="left" rowspan="1" colspan="1">Left Superior Temporal Pole</td><td align="left" rowspan="1" colspan="1">160</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">4.86</td><td align="left" rowspan="1" colspan="1">-28, 8, -25</td></tr><tr><td align="left" rowspan="1" colspan="1">Left Superior Occipital Gyrus</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">0.041</td><td align="left" rowspan="1" colspan="1">4.54</td><td align="left" rowspan="1" colspan="1">-24, -78, 37</td></tr><tr><td align="left" rowspan="1" colspan="1">Left Superior Temporal Gyrus</td><td align="left" rowspan="1" colspan="1">67</td><td align="left" rowspan="1" colspan="1">0.015</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">-50, -44, 13</td></tr><tr><td align="left" rowspan="1" colspan="1">Left Hippocampus</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">0.029</td><td align="left" rowspan="1" colspan="1">4.43</td><td align="left" rowspan="1" colspan="1">-12&#x02013;4&#x02013;13</td></tr><tr><td align="left" rowspan="1" colspan="1">(Left Putamen)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.95</td><td align="left" rowspan="1" colspan="1">(-20, 6, -5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Right Superior Temporal Gyrus</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">0.017</td><td align="left" rowspan="1" colspan="1">4.31</td><td align="left" rowspan="1" colspan="1">70, -44, 23</td></tr><tr><td align="left" rowspan="1" colspan="1">(Right Supramarginal Gurus)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.92</td><td align="left" rowspan="1" colspan="1">(70, -48, 33)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Cluster subpeaks are indicated in parenthesis, labelling based on AAL-library. FWE family wise error corrected p value.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec012"><title>Time radioactivity curves</title><p><sup>11</sup>C-GR205171 time radioactivity curves were similar in the cerebellum region, and decreased in patients across cortical and subcortical regions, see <xref ref-type="fig" rid="pone.0161563.g004">Fig 4</xref> for an illustration of time radioactivity curves in the anterior cingulate and cerebellum.</p><fig id="pone.0161563.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161563.g004</object-id><label>Fig 4</label><caption><title>Average Time Radioactivity Curves for the Anterior Cingulate (ACC) and the Cerebellum for Healthy Subjects (n = 18, solid lines) and Patients Pre-Treatment (n = 10, dashed lines).</title><p>X-axis is in seconds; y- axis is Standardized Uptake Values (normalized for dose and weight).</p></caption><graphic xlink:href="pone.0161563.g004"/></fig></sec><sec id="sec013"><title>Treatment effects</title><p>In seven out of the eight subjects examined after treatment, pain ratings decreased substantially (39 to 96%), but there were no significant changes in NK1-RA after treatment, either in the ROI analysis or in the SPM analysis. Furthermore, there were no significant correlations between changes in CNS NK1-RA and changes in pain ratings or peripheral tracer uptake.</p></sec></sec><sec sec-type="conclusions" id="sec014"><title>Discussion</title><p>We observed a general reduction of NK1-RA throughout the CNS in patients with chronic tennis elbow. This is in line with previous human studies on whiplash associated disorder [<xref rid="pone.0161563.ref029" ref-type="bibr">29</xref>] and an animal model that showed decreased hippocampal NK1 receptor gene expression in response to peripheral inflammation [<xref rid="pone.0161563.ref043" ref-type="bibr">43</xref>,<xref rid="pone.0161563.ref044" ref-type="bibr">44</xref>]. Moreover, NK1-RA levels were most reduced in the posterior insula cortex contralateral to the TE-arm, suggesting that the NK1-RA levels may be affected in a somatotopically representative manner. Ascending sensory pathways conveying proprioceptive and somatosensory information about the body&#x02019;s internal state terminate in the posterior insula [<xref rid="pone.0161563.ref045" ref-type="bibr">45</xref>]. Accordingly, the insula plays a key role in pain processing: For example, the posterior insula functional activation to muscle pain (without cutaneous sensation) [<xref rid="pone.0161563.ref046" ref-type="bibr">46</xref>], and treatment reversible gray matter volume reductions of the insula have been reported in hip osteoarthritis patients [<xref rid="pone.0161563.ref047" ref-type="bibr">47</xref>]. In a study on irritable bowel syndrome [<xref rid="pone.0161563.ref048" ref-type="bibr">48</xref>] treatment with a neurokin-1 receptor antagonist reduced pain induced functional activation of the posterior insula (and other regions). However, further studies are needed before the observed alterations can be linked to pain-specific roles (see [<xref rid="pone.0161563.ref049" ref-type="bibr">49</xref>] for a discussion on pain-specificity in the posterior insula). The present findings are difficult to directly attribute to the clinical condition, as NK1-RA levels were also reduced in regions not directly involved in pain processing, like the visual cortex, and did not correlate with pain ratings, symptom duration, peripheral inflammation or treatment response. Cortical NK1-tracer binding capacity has in previous investigations been noted high in the primary visual cortex [<xref rid="pone.0161563.ref024" ref-type="bibr">24</xref>]. Our findings may reflect the diverse function in the SP-NK1 system, and a general decrease in brain NK1-RA. This lack of relation to clinical symptoms may also be due to the relatively small sample size or it may reflect a true absence of clinical validity.</p><p>In an animal model with voluntary, highly repetitive, negligible force reaching task&#x02014;similar to that of a tennis elbow repetition injury&#x02014;SP levels and spinal cord NK1 receptor expression was up-regulated in the superficial lamina of spinal cord dorsal horns at 6 and 10 weeks. [<xref rid="pone.0161563.ref050" ref-type="bibr">50</xref>]. Other animal models have in a similar manner shown increased NK1 receptor gene expression in the dorsal horn in response to peripheral inflammation [<xref rid="pone.0161563.ref043" ref-type="bibr">43</xref>,<xref rid="pone.0161563.ref051" ref-type="bibr">51</xref>], while hippocampal NK1 receptor gene expression was simultaneously decreased [<xref rid="pone.0161563.ref043" ref-type="bibr">43</xref>]. This suggests the SP-NK1 receptor system modulates inflammation, nociception and CNS perception in a differential manner in peripheral tissue, spinal cord and brain [<xref rid="pone.0161563.ref043" ref-type="bibr">43</xref>,<xref rid="pone.0161563.ref052" ref-type="bibr">52</xref>]. It has been a matter of discussion whether <sup>11</sup>C-GR205171 can be displaced by endogenous SP [<xref rid="pone.0161563.ref006" ref-type="bibr">6</xref>; <xref rid="pone.0161563.ref039" ref-type="bibr">39</xref>]. In the present study, decreased availability of NK1 receptors could imply an increased synaptic level of endogenous SP, a decreased number of NK1 receptors or a combination.</p><p>Of note, the included patients all displayed peripherally elevated uptake of <sup>11</sup>C-GR205171 in the affected arm [<xref rid="pone.0161563.ref027" ref-type="bibr">27</xref>], but there was no correlation between peripheral uptake and central NK1-RA. This may, at least partly, be explained by differential modulation in peripheral tissue and brain [<xref rid="pone.0161563.ref043" ref-type="bibr">43</xref>]. Despite promising results in rodents, systemic blockade of NK1 receptors in human beings has not shown any convincing analgesic effect [<xref rid="pone.0161563.ref053" ref-type="bibr">53</xref>]. Transient NK1 receptor availability has been suggested as one possible explanation, as the NK1 receptor can be desensitized [<xref rid="pone.0161563.ref054" ref-type="bibr">54</xref>]as well as internalized [<xref rid="pone.0161563.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0161563.ref055" ref-type="bibr">55</xref>,<xref rid="pone.0161563.ref056" ref-type="bibr">56</xref>]. As the activation of NK1 receptors has different effects in peripheral tissue [<xref rid="pone.0161563.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0161563.ref021" ref-type="bibr">21</xref>], spinal cord [<xref rid="pone.0161563.ref023" ref-type="bibr">23</xref>,<xref rid="pone.0161563.ref051" ref-type="bibr">51</xref>]and brain [<xref rid="pone.0161563.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0161563.ref026" ref-type="bibr">26</xref>], it is possible that systemic blockade of the NK1 receptor may have only indirect effects on nociception and perception of pain. Overlapping pathways for signal transduction may be another explanation of why blockade of only the NK1 path does not have a significant clinical effect [<xref rid="pone.0161563.ref053" ref-type="bibr">53</xref>]. In humans there are several overlapping pathways for pain signaling, which may reflect the phylogenetic evolution of a robust sensory system.</p></sec><sec sec-type="conclusions" id="sec015"><title>Conclusions</title><p>The findings of this study suggest a role for the NK1 receptor in the CNS in a chronic, soft tissue-related pain condition such as chronic TE. The observed lower NK1 receptor availability in patients is interpreted as reflecting elevated endogenous SP levels creating receptor occupancy, desensitization and internalization, NK1 receptor downregulation, or a combination between these mechanisms. The CNS alterations were not specific to pain processing regions, and no effects of a three-month successful treatment program were observed, suggesting that the alterations are neither specific nor directly reflect the perception of pain.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0161563.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Allander</surname><given-names>E</given-names></name>. <article-title>Prevalence, incidence, and remission rates of some common rheumatic diseases or syndromes</article-title>. <source>Scand J Rheumatol</source>. <year>1974</year>;<volume>3</volume>:<fpage>145</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="pmid">4428194</pub-id></mixed-citation></ref><ref id="pone.0161563.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Assendelft</surname><given-names>W</given-names></name>, <name><surname>Green</surname><given-names>S</given-names></name>, <name><surname>Buchbinder</surname><given-names>R</given-names></name>, <name><surname>Struijs</surname><given-names>P</given-names></name>, <name><surname>Smidt</surname><given-names>N</given-names></name>. <article-title>Tennis elbow (lateral epicondylitis)</article-title>. <source>Clin Evid</source>. <year>2002</year>:<fpage>1290</fpage>&#x02013;<lpage>1300</lpage>. <pub-id pub-id-type="pmid">12603940</pub-id></mixed-citation></ref><ref id="pone.0161563.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Shiri</surname><given-names>R</given-names></name>, <name><surname>Viikari-Juntura</surname><given-names>E</given-names></name>, <name><surname>Varonen</surname><given-names>H</given-names></name>, <name><surname>Heliovaara</surname><given-names>M</given-names></name>. <article-title>Prevalence and determinants of lateral and medial epicondylitis: a population study</article-title>. <source>American journal of epidemiology</source>. <year>2006</year>;<volume>164</volume>:<fpage>1065</fpage>&#x02013;<lpage>1074</lpage>. <pub-id pub-id-type="pmid">16968862</pub-id></mixed-citation></ref><ref id="pone.0161563.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Kjaer</surname><given-names>M</given-names></name>, <name><surname>Langberg</surname><given-names>H</given-names></name>, <name><surname>Skovgaard</surname><given-names>D</given-names></name>, <name><surname>Olesen</surname><given-names>J</given-names></name>, <name><surname>Bulow</surname><given-names>J</given-names></name>, <name><surname>Krogsgaard</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>In vivo studies of peritendinous tissue in exercise</article-title>. <source>Scand J Med Sci Sports</source>. <year>2000</year>;<volume>10</volume>:<fpage>326</fpage>&#x02013;<lpage>331</lpage>. <pub-id pub-id-type="pmid">11085559</pub-id></mixed-citation></ref><ref id="pone.0161563.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Langberg</surname><given-names>H</given-names></name>, <name><surname>Skovgaard</surname><given-names>D</given-names></name>, <name><surname>Karamouzis</surname><given-names>M</given-names></name>, <name><surname>Bulow</surname><given-names>J</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>. <article-title>Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans</article-title>. <source>J Physiol</source>. <year>1999</year>;<volume>515</volume> (<issue>Pt 3</issue>):<fpage>919</fpage>&#x02013;<lpage>927</lpage>. <pub-id pub-id-type="pmid">10066916</pub-id></mixed-citation></ref><ref id="pone.0161563.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Paavola</surname><given-names>M</given-names></name>, <name><surname>Kannus</surname><given-names>P</given-names></name>, <name><surname>Jarvinen</surname><given-names>TA</given-names></name>, <name><surname>Jarvinen</surname><given-names>TL</given-names></name>, <name><surname>Jozsa</surname><given-names>L</given-names></name>, <name><surname>Jarvinen</surname><given-names>M</given-names></name>. <article-title>Treatment of tendon disorders. Is there a role for corticosteroid injection?</article-title>
<source>Foot Ankle Clin</source>. <year>2002</year>;<volume>7</volume>:<fpage>501</fpage>&#x02013;<lpage>513</lpage>. <pub-id pub-id-type="pmid">12512406</pub-id></mixed-citation></ref><ref id="pone.0161563.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Leadbetter</surname><given-names>WB</given-names></name>. <article-title>Cell-matrix response in tendon injury</article-title>. <source>Clin Sports Med</source>. <year>1992</year>;<volume>11</volume>:<fpage>533</fpage>&#x02013;<lpage>578</lpage>. <pub-id pub-id-type="pmid">1638640</pub-id></mixed-citation></ref><ref id="pone.0161563.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Fernandez-Carnero</surname><given-names>J</given-names></name>, <name><surname>Fernandez-de-Las-Penas</surname><given-names>C</given-names></name>, <name><surname>de la Llave-Rincon</surname><given-names>AI</given-names></name>, <name><surname>Ge</surname><given-names>HY</given-names></name>, <name><surname>Arendt-Nielsen</surname><given-names>L</given-names></name>. <article-title>Widespread mechanical pain hypersensitivity as sign of central sensitization in unilateral epicondylalgia: a blinded, controlled study</article-title>. <source>Clin J Pain</source>. <year>2009</year>;<volume>25</volume>:<fpage>555</fpage>&#x02013;<lpage>561</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/AJP.0b013e3181a68a040">10.1097/AJP.0b013e3181a68a040</ext-link></comment>
<pub-id pub-id-type="pmid">19692795</pub-id></mixed-citation></ref><ref id="pone.0161563.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Ruiz-Ruiz</surname><given-names>B</given-names></name>, <name><surname>Fernandez-de-Las-Penas</surname><given-names>C</given-names></name>, <name><surname>Ortega-Santiago</surname><given-names>R</given-names></name>, <name><surname>Arendt-Nielsen</surname><given-names>L</given-names></name>, <name><surname>Madeleine</surname><given-names>P</given-names></name>. <article-title>Topographical pressure and thermal pain sensitivity mapping in patients with unilateral lateral epicondylalgia</article-title>. <source>The journal of pain: official journal of the American Pain Society</source>. <year>2011</year>;<volume>12</volume>:<fpage>1040</fpage>&#x02013;<lpage>1048</lpage>.<pub-id pub-id-type="pmid">21680255</pub-id></mixed-citation></ref><ref id="pone.0161563.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Paavola</surname><given-names>M</given-names></name>, <name><surname>Kannus</surname><given-names>P</given-names></name>, <name><surname>Jarvinen</surname><given-names>TA</given-names></name>, <name><surname>Khan</surname><given-names>K</given-names></name>, <name><surname>Jozsa</surname><given-names>L</given-names></name>, <name><surname>Jarvinen</surname><given-names>M</given-names></name>. <article-title>Achilles tendinopathy</article-title>. <source>J Bone Joint Surg Am</source>. <year>2002</year>;<volume>84-A</volume>:<fpage>2062</fpage>&#x02013;<lpage>2076</lpage>. <pub-id pub-id-type="pmid">12429771</pub-id></mixed-citation></ref><ref id="pone.0161563.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Regan</surname><given-names>W</given-names></name>, <name><surname>Wold</surname><given-names>LE</given-names></name>, <name><surname>Coonrad</surname><given-names>R</given-names></name>, <name><surname>Morrey</surname><given-names>BF</given-names></name>. <article-title>Microscopic histopathology of chronic refractory lateral epicondylitis</article-title>. <source>Am J Sports Med</source>. <year>1992</year>;<volume>20</volume>:<fpage>746</fpage>&#x02013;<lpage>749</lpage>. <pub-id pub-id-type="pmid">1280910</pub-id></mixed-citation></ref><ref id="pone.0161563.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Goldie</surname><given-names>I</given-names></name>. <article-title>Epicondylitis Lateralis Humeri (Epicondylalgia or Tennis Elbow). a Pathogenetical Study</article-title>. <source>Acta Chir Scand Suppl</source>. <year>1964</year>;<volume>57</volume>:<issue>SUPPL 339</issue>:<fpage>331</fpage>+.</mixed-citation></ref><ref id="pone.0161563.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Ljung</surname><given-names>BO</given-names></name>, <name><surname>Alfredson</surname><given-names>H</given-names></name>, <name><surname>Forsgren</surname><given-names>S</given-names></name>. <article-title>Neurokinin 1-receptors and sensory neuropeptides in tendon insertions at the medial and lateral epicondyles of the humerus. Studies on tennis elbow and medial epicondylalgia</article-title>. <source>J Orthop Res</source>. <year>2004</year>;<volume>22</volume>:<fpage>321</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="pmid">15013091</pub-id></mixed-citation></ref><ref id="pone.0161563.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Andersson</surname><given-names>G</given-names></name>, <name><surname>Danielson</surname><given-names>P</given-names></name>, <name><surname>Alfredson</surname><given-names>H</given-names></name>, <name><surname>Forsgren</surname><given-names>S</given-names></name>. <article-title>Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon</article-title>. <source>Regul Pept</source>. <year>2008</year>;<volume>150</volume>:<fpage>81</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.regpep.2008.02.005">10.1016/j.regpep.2008.02.005</ext-link></comment>
<pub-id pub-id-type="pmid">18394729</pub-id></mixed-citation></ref><ref id="pone.0161563.ref015"><label>15</label><mixed-citation publication-type="book"><name><surname>Hoe-Hansen</surname><given-names>C</given-names></name>. <chapter-title>Subacromial inflammation; Clinical and experimental studies [Medicine]</chapter-title>
<publisher-loc>Linkoping</publisher-loc>: <publisher-name>University of Linkoping</publisher-name>
<year>2001</year>.</mixed-citation></ref><ref id="pone.0161563.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Ljung</surname><given-names>BO</given-names></name>, <name><surname>Forsgren</surname><given-names>S</given-names></name>, <name><surname>Friden</surname><given-names>J</given-names></name>. <article-title>Substance P and calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: implications for the etiology of tennis elbow</article-title>. <source>J Orthop Res</source>. <year>1999</year>;<volume>17</volume>:<fpage>554</fpage>&#x02013;<lpage>559</lpage>. <pub-id pub-id-type="pmid">10459762</pub-id></mixed-citation></ref><ref id="pone.0161563.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>O'Connor</surname><given-names>TM</given-names></name>, <name><surname>O'Connell</surname><given-names>J</given-names></name>, <name><surname>O'Brien</surname><given-names>DI</given-names></name>, <name><surname>Goode</surname><given-names>T</given-names></name>, <name><surname>Bredin</surname><given-names>CP</given-names></name>, <name><surname>Shanahan</surname><given-names>F</given-names></name>. <article-title>The role of substance P in inflammatory disease</article-title>. <source>J Cell Physiol</source>. <year>2004</year>;<volume>201</volume>:<fpage>167</fpage>&#x02013;<lpage>180</lpage>. <pub-id pub-id-type="pmid">15334652</pub-id></mixed-citation></ref><ref id="pone.0161563.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Quartara</surname><given-names>L</given-names></name>, <name><surname>Maggi</surname><given-names>CA</given-names></name>. <article-title>The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles</article-title>. <source>Neuropeptides</source>. <year>1998</year>;<volume>32</volume>:<fpage>1</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="pmid">9571643</pub-id></mixed-citation></ref><ref id="pone.0161563.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Pedersen-Bjergaard</surname><given-names>U</given-names></name>, <name><surname>Nielsen</surname><given-names>LB</given-names></name>, <name><surname>Jensen</surname><given-names>K</given-names></name>, <name><surname>Edvinsson</surname><given-names>L</given-names></name>, <name><surname>Jansen</surname><given-names>I</given-names></name>, <name><surname>Olesen</surname><given-names>J</given-names></name>. <article-title>Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle</article-title>. <source>Peptides</source>. <year>1991</year>;<volume>12</volume>:<fpage>333</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="pmid">1712469</pub-id></mixed-citation></ref><ref id="pone.0161563.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Leal</surname><given-names>EC</given-names></name>, <name><surname>Carvalho</surname><given-names>E</given-names></name>, <name><surname>Tellechea</surname><given-names>A</given-names></name>, <name><surname>Kafanas</surname><given-names>A</given-names></name>, <name><surname>Tecilazich</surname><given-names>F</given-names></name>, <name><surname>Kearney</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype</article-title>. <source>The American journal of pathology</source>. <year>2015</year>;<volume>185</volume>:<fpage>1638</fpage>&#x02013;<lpage>1648</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajpath.2015.02.011">10.1016/j.ajpath.2015.02.011</ext-link></comment>
<pub-id pub-id-type="pmid">25871534</pub-id></mixed-citation></ref><ref id="pone.0161563.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Delgado</surname><given-names>AV</given-names></name>, <name><surname>McManus</surname><given-names>AT</given-names></name>, <name><surname>Chambers</surname><given-names>JP</given-names></name>. <article-title>Exogenous administration of Substance P enhances wound healing in a novel skin-injury model</article-title>. <source>Experimental biology and medicine</source>. <year>2005</year>;<volume>230</volume>:<fpage>271</fpage>&#x02013;<lpage>280</lpage>. <pub-id pub-id-type="pmid">15792949</pub-id></mixed-citation></ref><ref id="pone.0161563.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Ni</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Peng</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Fang</surname><given-names>Y</given-names></name>, <name><surname>Yao</surname><given-names>M</given-names></name>. <article-title>Substance P induces inflammatory responses involving NF-kappaB in genetically diabetic mice skin fibroblasts co-cultured with macrophages</article-title>. <source>American journal of translational research</source>. <year>2016</year>;<volume>8</volume>:<fpage>2179</fpage>&#x02013;<lpage>2188</lpage>. <pub-id pub-id-type="pmid">27347325</pub-id></mixed-citation></ref><ref id="pone.0161563.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Mantyh</surname><given-names>PW</given-names></name>. <article-title>Neurobiology of substance P and the NK1 receptor</article-title>. <source>J Clin Psychiatry</source>. <year>2002</year>;<volume>63</volume>
<issue>Suppl 11</issue>:<fpage>6</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="pmid">12562137</pub-id></mixed-citation></ref><ref id="pone.0161563.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Hietala</surname><given-names>J</given-names></name>, <name><surname>Nyman</surname><given-names>MJ</given-names></name>, <name><surname>Eskola</surname><given-names>O</given-names></name>, <name><surname>Laakso</surname><given-names>A</given-names></name>, <name><surname>Gronroos</surname><given-names>T</given-names></name>, <name><surname>Oikonen</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain</article-title>. <source>Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging</source>. <year>2005</year>;<volume>7</volume>:<fpage>262</fpage>&#x02013;<lpage>272</lpage>.<pub-id pub-id-type="pmid">16155744</pub-id></mixed-citation></ref><ref id="pone.0161563.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Bergstrom</surname><given-names>M</given-names></name>, <name><surname>Hargreaves</surname><given-names>RJ</given-names></name>, <name><surname>Burns</surname><given-names>HD</given-names></name>, <name><surname>Goldberg</surname><given-names>MR</given-names></name>, <name><surname>Sciberras</surname><given-names>D</given-names></name>, <name><surname>Reines</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant</article-title>. <source>Biol Psychiatry</source>. <year>2004</year>;<volume>55</volume>:<fpage>1007</fpage>&#x02013;<lpage>1012</lpage>. <pub-id pub-id-type="pmid">15121485</pub-id></mixed-citation></ref><ref id="pone.0161563.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Herpfer</surname><given-names>I</given-names></name>, <name><surname>Lieb</surname><given-names>K</given-names></name>. <article-title>Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential</article-title>. <source>CNS drugs</source>. <year>2005</year>;<volume>19</volume>:<fpage>275</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="pmid">15813642</pub-id></mixed-citation></ref><ref id="pone.0161563.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>M</given-names></name>, <name><surname>Svardsudd</surname><given-names>K</given-names></name>, <name><surname>Appel</surname><given-names>L</given-names></name>, <name><surname>Engler</surname><given-names>H</given-names></name>, <name><surname>Aarnio</surname><given-names>M</given-names></name>, <name><surname>Gordh</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>PET-scan shows peripherally increased neurokinin 1 receptor availability in chronic tennis elbow: visualizing neurogenic inflammation?</article-title>
<source>PloS one</source>. <year>2013</year>;<volume>8</volume>:<fpage>e75859</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0075859">10.1371/journal.pone.0075859</ext-link></comment>
<pub-id pub-id-type="pmid">24155873</pub-id></mixed-citation></ref><ref id="pone.0161563.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>M</given-names></name>, <name><surname>Butler</surname><given-names>S</given-names></name>, <name><surname>Eriksson</surname><given-names>M</given-names></name>, <name><surname>Svardsudd</surname><given-names>K</given-names></name>. <article-title>A randomized controlled trial of eccentric vs. concentric graded exercise in chronic tennis elbow (lateral elbow tendinopathy)</article-title>. <source>Clinical rehabilitation</source>. <year>2014</year>.</mixed-citation></ref><ref id="pone.0161563.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Linnman</surname><given-names>C</given-names></name>, <name><surname>Appel</surname><given-names>L</given-names></name>, <name><surname>Furmark</surname><given-names>T</given-names></name>, <name><surname>Soderlund</surname><given-names>A</given-names></name>, <name><surname>Gordh</surname><given-names>T</given-names></name>, <name><surname>Langstrom</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Ventromedial prefrontal neurokinin 1 receptor availability is reduced in chronic pain</article-title>. <source>Pain</source>;<volume>149</volume>:<fpage>64</fpage>&#x02013;<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pain.2010.01.008">10.1016/j.pain.2010.01.008</ext-link></comment>
<pub-id pub-id-type="pmid">20137858</pub-id></mixed-citation></ref><ref id="pone.0161563.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Engman</surname><given-names>J</given-names></name>, <name><surname>Ahs</surname><given-names>F</given-names></name>, <name><surname>Furmark</surname><given-names>T</given-names></name>, <name><surname>Linnman</surname><given-names>C</given-names></name>, <name><surname>Pissiota</surname><given-names>A</given-names></name>, <name><surname>Appel</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Age, sex and NK1 receptors in the human brain&#x02014;a positron emission tomography study with [(1)(1)C]GR205171</article-title>. <source>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology</source>. <year>2012</year>;<volume>22</volume>:<fpage>562</fpage>&#x02013;<lpage>568</lpage>.<pub-id pub-id-type="pmid">22225860</pub-id></mixed-citation></ref><ref id="pone.0161563.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Hudak</surname><given-names>L</given-names></name>, <name><surname>Amadio</surname><given-names>PC</given-names></name>, <name><surname>Bombardier</surname><given-names>C</given-names></name>. <article-title>Development of an upper extremity outcome measure: the DASH (Disability of the Arm, Shoulder and Head)</article-title>. <source>Am J Industr Med</source>. <year>1996</year>;<volume>29</volume>:<fpage>602</fpage>&#x02013;<lpage>608</lpage>.</mixed-citation></ref><ref id="pone.0161563.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Atroshi</surname><given-names>I</given-names></name>, <name><surname>Gummesson</surname><given-names>C</given-names></name>, <name><surname>Andersson</surname><given-names>B</given-names></name>, <name><surname>Dahlgren</surname><given-names>E</given-names></name>, <name><surname>Johansson</surname><given-names>A</given-names></name>. <article-title>The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: reliability and validity of the Swedish version evaluated in 176 patients</article-title>. <source>Acta Orthop Scand</source>. <year>2000</year>;<volume>71</volume>:<fpage>613</fpage>&#x02013;<lpage>618</lpage>. <pub-id pub-id-type="pmid">11145390</pub-id></mixed-citation></ref><ref id="pone.0161563.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Bergstrom</surname><given-names>M</given-names></name>, <name><surname>Fasth</surname><given-names>KJ</given-names></name>, <name><surname>Kilpatrick</surname><given-names>G</given-names></name>, <name><surname>Ward</surname><given-names>P</given-names></name>, <name><surname>Cable</surname><given-names>KM</given-names></name>, <name><surname>Wipperman</surname><given-names>MD</given-names></name>, <etal>et al</etal>
<article-title>Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171&#x02014;PET studies in rhesus monkey</article-title>. <source>Neuropharmacology</source>. <year>2000</year>;<volume>39</volume>:<fpage>664</fpage>&#x02013;<lpage>670</lpage>. <pub-id pub-id-type="pmid">10728887</pub-id></mixed-citation></ref><ref id="pone.0161563.ref034"><label>34</label><mixed-citation publication-type="other">Siemens. ECAT Software version 7.1.1, Operating Instructions, Appendix B.</mixed-citation></ref><ref id="pone.0161563.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Patlak</surname><given-names>CS</given-names></name>, <name><surname>Blasberg</surname><given-names>RG</given-names></name>. <article-title>Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. Journal of cerebral blood flow and metabolism: official journal of the</article-title>
<source>International Society of Cerebral Blood Flow and Metabolism</source>. <year>1985</year>;<volume>5</volume>:<fpage>584</fpage>&#x02013;<lpage>590</lpage>.</mixed-citation></ref><ref id="pone.0161563.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Maihofner</surname><given-names>C</given-names></name>, <name><surname>Handwerker</surname><given-names>HO</given-names></name>, <name><surname>Birklein</surname><given-names>F</given-names></name>. <article-title>Functional imaging of allodynia in complex regional pain syndrome</article-title>. <source>Neurology</source>. <year>2006</year>;<volume>66</volume>:<fpage>711</fpage>&#x02013;<lpage>717</lpage>. <pub-id pub-id-type="pmid">16534108</pub-id></mixed-citation></ref><ref id="pone.0161563.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Pleger</surname><given-names>B</given-names></name>, <name><surname>Ragert</surname><given-names>P</given-names></name>, <name><surname>Schwenkreis</surname><given-names>P</given-names></name>, <name><surname>Forster</surname><given-names>AF</given-names></name>, <name><surname>Wilimzig</surname><given-names>C</given-names></name>, <name><surname>Dinse</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome</article-title>. <source>NeuroImage</source>. <year>2006</year>;<volume>32</volume>:<fpage>503</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="pmid">16753306</pub-id></mixed-citation></ref><ref id="pone.0161563.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Schweinhardt</surname><given-names>P</given-names></name>, <name><surname>Glynn</surname><given-names>C</given-names></name>, <name><surname>Brooks</surname><given-names>J</given-names></name>, <name><surname>McQuay</surname><given-names>H</given-names></name>, <name><surname>Jack</surname><given-names>T</given-names></name>, <name><surname>Chessell</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients</article-title>. <source>NeuroImage</source>. <year>2006</year>;<volume>32</volume>:<fpage>256</fpage>&#x02013;<lpage>265</lpage>. <pub-id pub-id-type="pmid">16679031</pub-id></mixed-citation></ref><ref id="pone.0161563.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Lebel</surname><given-names>A</given-names></name>, <name><surname>Becerra</surname><given-names>L</given-names></name>, <name><surname>Wallin</surname><given-names>D</given-names></name>, <name><surname>Moulton</surname><given-names>EA</given-names></name>, <name><surname>Morris</surname><given-names>S</given-names></name>, <name><surname>Pendse</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children</article-title>. <source>Brain: a journal of neurology</source>. <year>2008</year>;<volume>131</volume>:<fpage>1854</fpage>&#x02013;<lpage>1879</lpage>.<pub-id pub-id-type="pmid">18567621</pub-id></mixed-citation></ref><ref id="pone.0161563.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Linnman</surname><given-names>C</given-names></name>, <name><surname>Becerra</surname><given-names>L</given-names></name>, <name><surname>Lebel</surname><given-names>A</given-names></name>, <name><surname>Berde</surname><given-names>C</given-names></name>, <name><surname>Grant</surname><given-names>PE</given-names></name>, <name><surname>Borsook</surname><given-names>D</given-names></name>. <article-title>Transient and persistent pain induced connectivity alterations in pediatric complex regional pain syndrome</article-title>. <source>PloS one</source>. <year>2013</year>;<volume>8</volume>:<fpage>e57205</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0057205">10.1371/journal.pone.0057205</ext-link></comment>
<pub-id pub-id-type="pmid">23526938</pub-id></mixed-citation></ref><ref id="pone.0161563.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Tzourio-Mazoyer</surname><given-names>N</given-names></name>, <name><surname>Landeau</surname><given-names>B</given-names></name>, <name><surname>Papathanassiou</surname><given-names>D</given-names></name>, <name><surname>Crivello</surname><given-names>F</given-names></name>, <name><surname>Etard</surname><given-names>O</given-names></name>, <name><surname>Delcroix</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain</article-title>. <source>NeuroImage</source>. <year>2002</year>;<volume>15</volume>:<fpage>273</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="pmid">11771995</pub-id></mixed-citation></ref><ref id="pone.0161563.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Linnman</surname><given-names>C</given-names></name>, <name><surname>Moulton</surname><given-names>EA</given-names></name>, <name><surname>Barmettler</surname><given-names>G</given-names></name>, <name><surname>Becerra</surname><given-names>L</given-names></name>, <name><surname>Borsook</surname><given-names>D</given-names></name>. <article-title>Neuroimaging of the periaqueductal gray: state of the field</article-title>. <source>NeuroImage</source>. <year>2012</year>;<volume>60</volume>:<fpage>505</fpage>&#x02013;<lpage>522</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuroimage.2011.11.095">10.1016/j.neuroimage.2011.11.095</ext-link></comment>
<pub-id pub-id-type="pmid">22197740</pub-id></mixed-citation></ref><ref id="pone.0161563.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Duric</surname><given-names>V</given-names></name>, <name><surname>McCarson</surname><given-names>KE</given-names></name>. <article-title>Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippocampus during inflammatory pain</article-title>. <source>Molecular pain</source>. <year>2007</year>;<volume>3</volume>:<fpage>32</fpage>
<pub-id pub-id-type="pmid">17974009</pub-id></mixed-citation></ref><ref id="pone.0161563.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Duric</surname><given-names>V</given-names></name>, <name><surname>McCarson</surname><given-names>KE</given-names></name>. <article-title>Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress</article-title>. <source>Neuroscience</source>. <year>2005</year>;<volume>133</volume>:<fpage>999</fpage>&#x02013;<lpage>1006</lpage>. <pub-id pub-id-type="pmid">15964488</pub-id></mixed-citation></ref><ref id="pone.0161563.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Craig</surname><given-names>AD</given-names></name>. <article-title>How do you feel&#x02014;now? The anterior insula and human awareness</article-title>. <source>Nature reviews Neuroscience</source>. <year>2009</year>;<volume>10</volume>:<fpage>59</fpage>&#x02013;<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrn2555">10.1038/nrn2555</ext-link></comment>
<pub-id pub-id-type="pmid">19096369</pub-id></mixed-citation></ref><ref id="pone.0161563.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Uematsu</surname><given-names>H</given-names></name>, <name><surname>Shibata</surname><given-names>M</given-names></name>, <name><surname>Miyauchi</surname><given-names>S</given-names></name>, <name><surname>Mashimo</surname><given-names>T</given-names></name>. <article-title>Brain imaging of mechanically induced muscle versus cutaneous pain</article-title>. <source>Neuroscience research</source>. <year>2011</year>;<volume>70</volume>:<fpage>78</fpage>&#x02013;<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neures.2011.01.015">10.1016/j.neures.2011.01.015</ext-link></comment>
<pub-id pub-id-type="pmid">21291923</pub-id></mixed-citation></ref><ref id="pone.0161563.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Rodriguez-Raecke</surname><given-names>R</given-names></name>, <name><surname>Niemeier</surname><given-names>A</given-names></name>, <name><surname>Ihle</surname><given-names>K</given-names></name>, <name><surname>Ruether</surname><given-names>W</given-names></name>, <name><surname>May</surname><given-names>A</given-names></name>. <article-title>Brain gray matter decrease in chronic pain is the consequence and not the cause of pain</article-title>. <source>The Journal of neuroscience: the official journal of the Society for Neuroscience</source>. <year>2009</year>;<volume>29</volume>:<fpage>13746</fpage>&#x02013;<lpage>13750</lpage>.<pub-id pub-id-type="pmid">19889986</pub-id></mixed-citation></ref><ref id="pone.0161563.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Tillisch</surname><given-names>K</given-names></name>, <name><surname>Labus</surname><given-names>J</given-names></name>, <name><surname>Nam</surname><given-names>B</given-names></name>, <name><surname>Bueller</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>S</given-names></name>, <name><surname>Suyenobu</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study</article-title>. <source>Alimentary pharmacology &#x00026; therapeutics</source>. <year>2012</year>;<volume>35</volume>:<fpage>360</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">22221140</pub-id></mixed-citation></ref><ref id="pone.0161563.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>KD</given-names></name>, <name><surname>Bushnell</surname><given-names>MC</given-names></name>, <name><surname>Iannetti</surname><given-names>GD</given-names></name>, <name><surname>St Lawrence</surname><given-names>K</given-names></name>, <name><surname>Coghill</surname><given-names>R</given-names></name>. <article-title>Evidence against pain specificity in the dorsal posterior insula</article-title>. <source>F1000Research</source>. <year>2015</year>;<volume>4</volume>:<fpage>362</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.12688/f1000research.6833.1">10.12688/f1000research.6833.1</ext-link></comment>
<pub-id pub-id-type="pmid">26401267</pub-id></mixed-citation></ref><ref id="pone.0161563.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Elliott</surname><given-names>MB</given-names></name>, <name><surname>Barr</surname><given-names>AE</given-names></name>, <name><surname>Barbe</surname><given-names>MF</given-names></name>. <article-title>Spinal substance P and neurokinin-1 increase with high repetition reaching</article-title>. <source>Neurosci Lett</source>. <year>2009</year>;<volume>454</volume>:<fpage>33</fpage>&#x02013;<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neulet.2009.01.037">10.1016/j.neulet.2009.01.037</ext-link></comment>
<pub-id pub-id-type="pmid">19429049</pub-id></mixed-citation></ref><ref id="pone.0161563.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>McCarson</surname><given-names>KE</given-names></name>, <name><surname>Krause</surname><given-names>JE</given-names></name>. <article-title>NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception</article-title>. <source>The Journal of neuroscience: the official journal of the Society for Neuroscience</source>. <year>1994</year>;<volume>14</volume>:<fpage>712</fpage>&#x02013;<lpage>720</lpage>.<pub-id pub-id-type="pmid">8301359</pub-id></mixed-citation></ref><ref id="pone.0161563.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Backman</surname><given-names>LJ</given-names></name>, <name><surname>Fong</surname><given-names>G</given-names></name>, <name><surname>Andersson</surname><given-names>G</given-names></name>, <name><surname>Scott</surname><given-names>A</given-names></name>, <name><surname>Danielson</surname><given-names>P</given-names></name>. <article-title>Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>:<fpage>e27209</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0027209">10.1371/journal.pone.0027209</ext-link></comment>
<pub-id pub-id-type="pmid">22069500</pub-id></mixed-citation></ref><ref id="pone.0161563.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Hill</surname><given-names>R</given-names></name>. <article-title>NK1 (substance P) receptor antagonists&#x02014;why are they not analgesic in humans?</article-title>
<source>Trends Pharmacol Sci</source>. <year>2000</year>;<volume>21</volume>:<fpage>244</fpage>&#x02013;<lpage>246</lpage>. <pub-id pub-id-type="pmid">10871891</pub-id></mixed-citation></ref><ref id="pone.0161563.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Garland</surname><given-names>AM</given-names></name>, <name><surname>Grady</surname><given-names>EF</given-names></name>, <name><surname>Lovett</surname><given-names>M</given-names></name>, <name><surname>Vigna</surname><given-names>SR</given-names></name>, <name><surname>Frucht</surname><given-names>MM</given-names></name>, <name><surname>Krause</surname><given-names>JE</given-names></name>, <etal>et al</etal>
<article-title>Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors</article-title>. <source>Molecular pharmacology</source>. <year>1996</year>;<volume>49</volume>:<fpage>438</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="pmid">8643083</pub-id></mixed-citation></ref><ref id="pone.0161563.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Mantyh</surname><given-names>PW</given-names></name>, <name><surname>Allen</surname><given-names>CJ</given-names></name>, <name><surname>Ghilardi</surname><given-names>JR</given-names></name>, <name><surname>Rogers</surname><given-names>SD</given-names></name>, <name><surname>Mantyh</surname><given-names>CR</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>1995</year>;<volume>92</volume>:<fpage>2622</fpage>&#x02013;<lpage>2626</lpage>. <pub-id pub-id-type="pmid">7535928</pub-id></mixed-citation></ref><ref id="pone.0161563.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Bowden</surname><given-names>JJ</given-names></name>, <name><surname>Garland</surname><given-names>AM</given-names></name>, <name><surname>Baluk</surname><given-names>P</given-names></name>, <name><surname>Lefevre</surname><given-names>P</given-names></name>, <name><surname>Grady</surname><given-names>EF</given-names></name>, <name><surname>Vigna</surname><given-names>SR</given-names></name>, <etal>et al</etal>
<article-title>Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1994</year>;<volume>91</volume>:<fpage>8964</fpage>&#x02013;<lpage>8968</lpage>. <pub-id pub-id-type="pmid">7522326</pub-id></mixed-citation></ref></ref-list></back></article>